We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+7.36%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$20.9B
AUM Growth
+$846M
(+4.2%)
Cap. Flow
-$310M
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
37.91%
Holding
586
New
60
Increased
176
Reduced
234
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$206M |
| 2 |
Alibaba
BABA
|
+$155M |
| 3 |
Microchip Technology
MCHP
|
+$118M |
| 4 |
Illumina
ILMN
|
+$97.5M |
| 5 |
Estee Lauder
EL
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$159M |
| 2 |
AGN
Allergan plc
AGN
|
+$137M |
| 3 |
Comcast
CMCSA
|
+$120M |
| 4 |
Honeywell
HON
|
+$113M |
| 5 |
Aptiv
APTV
|
+$98.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.72% |
| 2 | Communication Services | 16% |
| 3 | Healthcare | 14.9% |
| 4 | Consumer Discretionary | 14.14% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Cencora
COR
$60.3B
| $349K | ﹤0.01% |
3,694
+3,414
| +1,219% | +$304K |
|
377
Stratasys
SSYS
$697M
| $344K | ﹤0.01% |
14,763
-72,910
| -83% | -$1.88M |
|
378
Merit Medical Systems
MMSI
$4.43B
| $343K | ﹤0.01% |
+9,000
| New | +$301K |
|
379
HCA Healthcare
HCA
$84.8B
| $340K | ﹤0.01% |
3,894
-321
| -8% | -$27.2K |
|
|
RXDX
380
DELISTED
Ignyta, Inc.
RXDX
| $331K | ﹤0.01% |
+32,000
| New | +$260K |
|
381
Woodward
WWD
$25B
| $325K | ﹤0.01% |
4,811
+9
| +0.2% | +$614 |
|
|
WOOF
382
DELISTED
VCA Inc.
WOOF
| $316K | ﹤0.01% |
3,419
-29,488
| -90% | -$2.71M |
|
383
EOG Resources
EOG
$78B
| $299K | ﹤0.01% |
3,300
-4,969
| -60% | -$458K |
|
384
Stantec
STN
$7.69B
| $253K | ﹤0.01% |
10,070
| – | – |
|
385
AbbVie
ABBV
$458B
| $232K | ﹤0.01% |
3,200
+3,000
| +1,500% | +$202K |
|
|
SIOX
386
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $232K | ﹤0.01% |
1,250
| – | – |
|
387
Verisk Analytics
VRSK
$26.4B
| $214K | ﹤0.01% |
2,532
-122,408
| -98% | -$9.91M |
|
388
Chevron
CVX
$388B
| $213K | ﹤0.01% |
2,040
-2,150
| -51% | -$228K |
|
|
BPMC
389
DELISTED
Blueprint Medicines
BPMC
| $203K | ﹤0.01% |
+4,000
| New | +$170K |
|
|
AMTD
390
DELISTED
TD Ameritrade Holding Corp
AMTD
| $173K | ﹤0.01% |
4,021
+7
| +0.2% | +$272 |
|
391
PetMed Express
PETS
$42.5M
| $162K | ﹤0.01% |
+4,000
| New | +$124K |
|
|
ITCI
392
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $161K | ﹤0.01% |
+13,000
| New | +$151K |
|
393
Axalta
AXTA
$7.01B
| $159K | ﹤0.01% |
4,957
| – | – |
|
394
Teladoc Health
TDOC
$1.58B
| $139K | ﹤0.01% |
+4,000
| New | +$117K |
|
|
GBT
395
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $137K | ﹤0.01% |
5,000
-11,000
| -69% | -$327K |
|
396
Euronet Worldwide
EEFT
$3.02B
| $129K | ﹤0.01% |
1,472
-144,351
| -99% | -$12.4M |
|
397
Peapack-Gladstone Financial
PGC
$822M
| $129K | ﹤0.01% |
4,138
| – | – |
|
398
Wabtec
WAB
$51.1B
| $123K | ﹤0.01% |
1,344
-121
| -8% | -$10.1K |
|
|
TVRD
399
Tvardi Therapeutics
TVRD
$23.5M
| $123K | ﹤0.01% |
+222
| New | +$141K |
|
400
Ambarella
AMBA
$2.99B
| $121K | ﹤0.01% |
2,500
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2017 Portfolio in Review
As of Q2 2017, Fred Alger Management held 586 positions worth $20.9B, up 4.2% from $20.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Fred Alger Management's Q2 2017 filing shows 60 new, 176 increased, 234 reduced and 47 closed positions. Its largest new stake was Estee Lauder: 989,288 shares worth $95M. The largest sale was Alphabet (Google) Class C, an estimated $159M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Communication Services and Healthcare.
- Fred Alger Management's largest Q2 2017 buy was Estee Lauder: 989,288 shares worth $95M.
- Fred Alger Management added most to McDonald's in Q2 2017, an estimated $206M increase.
- Fred Alger Management's biggest Q2 2017 reduction was Alphabet (Google) Class C, cutting an estimated $159M.
- Fred Alger Management fully exited Yahoo Inc in Q2 2017, selling an estimated $91.2M.
- Fred Alger Management's ten largest holdings make up 38% of its $20.9B portfolio in Q2 2017.
- Fred Alger Management opened 60 new positions and closed 47 in Q2 2017.
- Fred Alger Management's portfolio value rose 4.2% quarter-over-quarter to $20.9B.
Based on Fred Alger Management's 13F filing for Q2 2017, filed 14 Aug 2017.